Vanda Pharmaceuticals Inc. (VNDA) — Stock Score Summary

Vanda Pharmaceuticals Inc. (VNDA) has a MoatMap StockRank of 57/100 based on Quality (38/100), Value (46/100), and Momentum (59/100) factor scores. The current signal is HOLD. Vanda Pharmaceuticals is a small biotech company with declining sales of its key drugs and low-quality metrics. It lacks any alignment with our macro themes and fails all our quality and moat lenses.

Vanda Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for central nervous system (CNS) disorders. Its competitive moat is built upon its proprietary, approved products like Hetlioz for non-24-hour sleep-wake disorder and Fanapt for schizophrenia, addressing significant unmet medical needs in niche patient populations. Vanda maintains a focused R&D pipeline aimed at expanding its CNS franchise.

Key Financial Metrics

Price$6.09
Market Cap$399M
P/E (Forward)31.10
Price/Book1.12
Return on Equity-60.5%
Return on Invested Capital-44.0%
Debt/Equity4.66
Gross Margin94.2%
Operating Margin-97.1%
Revenue Growth3.4%
Free Cash Flow$-83M

Vanda Pharmaceuticals Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Vanda Pharmaceuticals Inc.’s (VNDA) StockRank?
MoatMap’s StockRank for Vanda Pharmaceuticals Inc. (VNDA) is 57/100, with a Hold signal. It is a composite of Quality (38), Value (46), and Momentum (59) factor ranks across MoatMap’s 19,000+ stock universe.
Does Vanda Pharmaceuticals Inc. have an economic moat?
Vanda Pharmaceuticals Inc. (VNDA) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Vanda Pharmaceuticals Inc. a buy, hold, or sell?
MoatMap’s current signal for Vanda Pharmaceuticals Inc. (VNDA) is Hold, based on a StockRank of 57/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Vanda Pharmaceuticals Inc. in?
Vanda Pharmaceuticals Inc. (VNDA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksVNDA deep dive reportAI ChampionsHow we score stocksSense-check another stock